top of page

Evaluating global medical cannabis regulatory regimes: Lessons to be learned for the UK

Drug Science
Jan 31, 2020
1 min read

Updated: Apr 4, 2024

Read the Full Report

#MCWG #medicalcannabis #report

Recent Posts

Drug Science response to Ketamine Harms Assessment

Drug Science response to Ketamine Harms Assessment

Germany Pioneers Compassionate Psilocybin Access for Treatment-Resistant Depression in EU First

Germany Pioneers Compassionate Psilocybin Access for Treatment-Resistant Depression in EU First

UK Government supports ACMD plan to enable research with schedule 1 medicines such as psilocybin and MDMA

UK Government supports ACMD plan to enable research with schedule 1 medicines such as psilocybin and MDMA

Keep up with developments in drug science

Reading, engaging with, and sharing our publications, papers and commentary gives evidence-based science and policy the audience it needs and deserves.

bottom of page